Unlock instant, AI-driven research and patent intelligence for your innovation.

New application of human MED19 genes in tumor therapy

A gene, tumor technology, applied in the field of new use of human MED19 gene in tumor therapy

Active Publication Date: 2013-05-15
SHANGHAI GENECHEM
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The MED19 gene is located at the 11q12.1 position of the chromosome, encoding a protein homologous to the transcriptional mediator MED19 that promotes transcription in yeast, and there is no clear functional report in mammals

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New application of human MED19 genes in tumor therapy
  • New application of human MED19 genes in tumor therapy
  • New application of human MED19 genes in tumor therapy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Example 1: Preparation of human MED19 gene efficient interference lentivirus

[0045] The gene information of MED19 (NM_153450) was retrieved from genbank; an effective siRNA target for MED19 was designed by using the design software genechem accumulated and summarized by Jikai Gene Chemical Technology Co., Ltd. for many years. The siRNA target sequence is: GGTGAAGGAGAAGCTAAGT.

[0046] Synthesize double-stranded DNA oligo sequences with sticky ends containing Hpa I and Xho I restriction sites at both ends for the siRNA target, as shown in the table below;

[0047] The double-stranded DNA oligo with sticky ends containing Hpa I and Xho I restriction sites at both ends is:

[0048] No.

5’

STEM

Loop

STEM

3’

1-F

T

GGTGAAGGAGAAGCTAAGT

TTCAAGAGA

ACTTAGCTTCTCCTTCACC

TTTTTTC

1-R

TCGAGAAAAAAA

GGTGAAGGAGAAGCTAAGT

TCTCTTGAA

ACTTAGCTTCTCCTTCACC

A

[0049] Construction of lentivir...

Embodiment 2

[0053] Example 2: The method of immunohistochemistry detects the expression difference of MED19 in normal hyperplastic tissue and cancerous tissue (taking prostate tissue as an example)

[0054] There were 30 patients with prostate tumors and 10 patients with benign prostatic hyperplasia. Paraffin sections of surgically resected prostate tissue were dewaxed and rehydrated with xylene and graded ethanol, boiled in citrate buffer for antigen retrieval, blocked with 10% BSA at 37°C for 1 hr, added primary antibody to MED19, the working concentration of the primary antibody was 1 μg / ml , and incubated overnight at 4°C with the primary antibody. The corresponding secondary antibody was added for staining, the secondary antibody was HRP-labeled antibody against the species of the primary antibody, and the working concentration was diluted 1:100. 37 degrees Celsius, one hour. After washing with PBS, develop color with DAB solution, room temperature for 3-5 minutes, rinse with tap w...

Embodiment 3

[0057] Example 3: MTT method to detect the proliferation ability of tumor cells infected with GCG-973-siRNA

[0058] pko (colorectal cancer cell line) cells were trypsinized and seeded in a 12-well plate at a cell density of 10-15%. The next day, replace with fresh medium containing 5ug / ml polybrene. Add GCG-973-siRNA lentivirus to the culture plate according to MOI 10, and replace with fresh medium after 12-24 hours of infection. After 72 hours of infection, the fluorescence was observed under a fluorescence microscope, and the infection efficiency reached 90%.

[0059] Trypsinize the virus-infected cells in the logarithmic growth phase, resuspend the complete medium into a cell suspension; inoculate in a 96-well plate, 100 μl per well; culture in a 5% CO2 incubator at 37°C; before the termination of the culture Add 10 μl of 5 mg / ml MTT at 4 hours; add 100 μl DMSO to stop the reaction after discarding the culture medium; detect the OD value with a microplate reader at 570 n...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of biology, and particularly relates to new application of human MED19 genes in tumor therapy. Researches show that the MED19 has important biological function in genesis and development of tumors; and compared with normal tissues, the MED19 genes are widely and high expressed in tumor tissues. After RNA distributed slow virus designed aiming at the human MED19 genes is specifically distributed and the expression of the MED19 genes is adjusted downwards, the growth and the intrusion of tumor cells can be inhibited, the apoptosis of the tumor cells can be promoted, and tumor formation of the tumor cells can be inhibited. The MED19 genes can be used as molecular targets for tumor therapy. siRNA silence aiming at the MED19 genes can be used as a novel tool for the tumor therapy.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to the new application of human MED19 gene in tumor treatment. Background technique [0002] The phenomenon of RNA interference is a conserved defense mechanism in biological evolution that arises autonomously within cells. Considered to be the main effector of RNA interference, siRNA has become a powerful tool to study the function of mammalian gene products by inhibiting the expression of target genes. Direct transfection of synthetic siRNA can specifically inhibit the expression of homologous genes in mammalian cells, but siRNA in cells is easily degraded, so this method cannot achieve stable RNA interference. Lentiviral vectors have high infection efficiency in mammals, low immunogenicity, and can infect both dividing and non-dividing cells. Due to these characteristics of viral vectors, lentivirus-mediated RNA interference can stably express siRNA in various mammalian...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K48/00A61P35/00C12Q1/68C12N7/01
Inventor 韦有恒劳昕元季国庆杨敏高博曹跃琼
Owner SHANGHAI GENECHEM